BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 7528390)

  • 21. Stereology, a new morphological method of study prostatic function and disease.
    Bartsch G; Frick J; Rohr HP
    Prog Clin Biol Res; 1976; 6():123-41. PubMed ID: 66686
    [No Abstract]   [Full Text] [Related]  

  • 22. [Chronobiology of the benign growth of the prostate gland].
    Ruiz de Burgos y Moreno JE
    An R Acad Nac Med (Madr); 1990; 107(2):223-49. PubMed ID: 1708213
    [No Abstract]   [Full Text] [Related]  

  • 23. [Pathophysiology of benign prostatic hyperplasia].
    Frick J
    Wien Med Wochenschr; 1996; 146(8):158-60. PubMed ID: 8767399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The importance of stromal tissue in benign prostatic hyperplasia: morphological, immunofluorescence and endocrinological investigations.
    Bartsch G; Brüngger A; Schweikert U; Hintner H; Stanzl U; Marth C; Daxenbichler G; Rohr HP
    Prog Clin Biol Res; 1984; 145():159-79. PubMed ID: 6201873
    [No Abstract]   [Full Text] [Related]  

  • 25. Anatomopathologic basis for the cryosurgery of the prostate.
    Vernet SG
    Minerva Med; 1974 Oct; 65(70):3679-87. PubMed ID: 4138687
    [No Abstract]   [Full Text] [Related]  

  • 26. Phenotypic characterization of the infiltrating immune cells in normal prostate, benign nodular prostatic hyperplasia and prostatic adenocarcinoma.
    Hussein MR; Al-Assiri M; Musalam AO
    Exp Mol Pathol; 2009 Apr; 86(2):108-13. PubMed ID: 19111537
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The natural history of benign prostatic hyperplasia.
    Harv Mens Health Watch; 1998 Mar; 2(8):1-5. PubMed ID: 9516320
    [No Abstract]   [Full Text] [Related]  

  • 28. [Relation between benign prostatic hyperplasia and obesity and estrogen].
    Matsuda T; Abe H; Suda K
    Rinsho Byori; 2004 Apr; 52(4):291-4. PubMed ID: 15164594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A study of the physical properties of the prostate (first report)--prostatic pressure coefficient and presumed circle area ratio in benign prostatic hypertrophy].
    Ohnishi K
    Nihon Hinyokika Gakkai Zasshi; 1986 Sep; 77(9):1377-87. PubMed ID: 2433484
    [No Abstract]   [Full Text] [Related]  

  • 30. [Role of hormonal factors in the pathogenesis of prostatic hypertrophy].
    Baranowska B; Migdalska B; Szymanowski J; Kozłowicz I
    Pol Tyg Lek; 1977 Feb; 32(6):251-3. PubMed ID: 65771
    [No Abstract]   [Full Text] [Related]  

  • 31. [Regulation of prostatic growth, pathogenesis of prostatic adenoma and cancer].
    Darenkov AF; Evdokimov VV; Alfimov AE
    Vestn Ross Akad Med Nauk; 1994; (11):50-9. PubMed ID: 7530531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A journey through your prostate.
    Kirby R
    Trans Med Soc Lond; 2002-2003; 119():53-75. PubMed ID: 17184032
    [No Abstract]   [Full Text] [Related]  

  • 33. [Benign prostatic hyperplasia--an old disease picture--from a new viewpoint].
    Hartung R
    Urologe A; 1995 Mar; 34(2):77-83. PubMed ID: 7538713
    [No Abstract]   [Full Text] [Related]  

  • 34. Engineered FGF-2 expression induces glandular epithelial hyperplasia in the murine prostatic dorsal lobe.
    Konno-Takahashi N; Takeuchi T; Nishimatsu H; Kamijo T; Tomita K; Schalken JA; Teshima S; Kitamura T
    Eur Urol; 2004 Jul; 46(1):126-32. PubMed ID: 15183558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinico-morphologic parallels of prostatic adenoma in various age groups].
    Kuchuk IaI
    Urol Nefrol (Mosk); 1989; (2):64-8. PubMed ID: 2471343
    [No Abstract]   [Full Text] [Related]  

  • 36. Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma.
    Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
    Prostate; 2001 May; 47(3):149-63. PubMed ID: 11351344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased cell proliferation and contractility of prostate in insulin resistant rats: linking hyperinsulinemia with benign prostate hyperplasia.
    Vikram A; Jena GB; Ramarao P
    Prostate; 2010 Jan; 70(1):79-89. PubMed ID: 19790233
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of growth factors in the pathogenesis of BPH.
    Habib FK
    Prog Clin Biol Res; 1994; 386():43-50. PubMed ID: 7528412
    [No Abstract]   [Full Text] [Related]  

  • 39. Benign prostatic hypertrophy and uterine leiomyomas: analogous or dissimilar diseases?
    Robboy SJ; Lawrence WD; Cunha GR
    Prog Clin Biol Res; 1984; 145():67-79. PubMed ID: 6201884
    [No Abstract]   [Full Text] [Related]  

  • 40. Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma.
    Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
    Prostate; 2001 Aug; 48(3):210-24. PubMed ID: 11494337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.